Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ele Ferrannini

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Reference Values

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Nannipieri M; Cecchetti F; Anselmino M; Camastra S; Niccolini P; Lamacchia M; Rossi M; Iervasi G; Ferrannini E
Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.
Vanni Ester; Abate Maria Lorena; Gentilcore Elena; Hickman Ingrid; Gambino Roberto; Cassader Maurizio; Smedile Antonina; Ferrannini Ele; Rizzetto Mario; Marchesini Giulio; Gastaldelli Amalia; Bugianesi Elisabetta
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.
Bonuccelli Sandra; Muscelli Elza; Gastaldelli Amalia; Barsotti Elisabetta; Astiarraga Brenno D; Holst Jens J; Mari Andrea; Ferrannini Ele
Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ele Ferrannini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nannipieri M; Cecchetti F; Anselmino M; Camastra S; Niccolini P; Lamacchia M; Rossi M; Iervasi G; Ferrannini E
Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss.
International journal of obesity (2005) 2009;33(9):1001-6.
2009: Vanni Ester; Abate Maria Lorena; Gentilcore Elena; Hickman Ingrid; Gambino Roberto; Cassader Maurizio; Smedile Antonina; Ferrannini Ele; Rizzetto Mario; Marchesini Giulio; Gastaldelli Amalia; Bugianesi Elisabetta
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2009;50(3):697-706.
2009: Bonuccelli Sandra; Muscelli Elza; Gastaldelli Amalia; Barsotti Elisabetta; Astiarraga Brenno D; Holst Jens J; Mari Andrea; Ferrannini Ele
Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms.
American journal of physiology. Endocrinology and metabolism 2009;297(2):E532-7.
2009: Spanheimer Robert; Betteridge D John; Tan Meng H; Ferrannini Ele; Charbonnel Bernard;
Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14).
The American journal of cardiology 2009;104(2):234-9.
2009: Fonseca Vivian; Inzucchi Silvio E; Ferrannini Ele
Redefining the diagnosis of diabetes using glycated hemoglobin.
Diabetes care 2009;32(7):1344-5.
2009: Gastaldelli Amalia; Casolaro Arturo; Ciociaro Demetrio; Frascerra Silvia; Nannipieri Monica; Buzzigoli Emma; Ferrannini Ele
Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.
American journal of physiology. Endocrinology and metabolism 2009;297(1):E225-30.
2009: Ferrannini Ele
Insulin resistance versus beta-cell dysfunction in the pathogenesis of type 2 diabetes.
Current diabetes reports 2009;9(3):188-9.
2009: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Ferrari Silvia Martina; Frascerra Silvia; Pampana Alessandro; Panicucci Erica; Carpi Angelo; Nicolini Andrea; Ferrannini Ele
CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2009;29(6):345-51.
2009: Santini Eleonora; Cuccato Sabina; Madec Stephanie; Chimenti Daniele; Ferrannini Ele; Solini Anna
Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype.
Endocrinology 2009;150(6):2596-602.
2009: Antonelli Alessandro; Ferrari Silvia Martina; Fallahi Poupak; Berti Piero; Materazzi Gabriele; Minuto Michele; Giannini Riccardo; Marchetti Ivo; Barani Lucio; Basolo Fulvio; Ferrannini Ele; Miccoli Paolo
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells.
Clinical endocrinology 2009;70(6):946-53.
2009: Antonelli Alessandro; Ferrari Silvia Martina; Fallahi Poupak; Frascerra Silvia; Santini Eleonora; Franceschini Stefano Sellari; Ferrannini Ele
Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
The Journal of clinical endocrinology and metabolism 2009;94(5):1803-9.
2009: Ferrannini E; Massari M; Nannipieri M; Natali A; Ridaura R Lopez; Gonzales-Villalpando C
Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.
Diabetologia 2009;52(5):818-24.
2009: Nannipieri M; Cecchetti F; Anselmino M; Mancini E; Marchetti G; Bonotti A; Baldi S; Solito B; Giannetti M; Pinchera A; Santini F; Ferrannini E
Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis.
Obesity surgery 2009;19(4):467-74.
2009: Ferrannini Ele; Mingrone Geltrude
Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes.
Diabetes care 2009;32(3):514-20.
2009: Ferrannini E; Fonseca V; Zinman B; Matthews D; Ahrén B; Byiers S; Shao Q; Dejager S
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
Diabetes, obesity & metabolism 2009;11(2):157-66.
2009: Antonelli A; Fallahi P; Delle Sedie A; Ferrari S M; Maccheroni M; Bombardieri S; Riente L; Ferrannini E
High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis.
Clinical and experimental rheumatology 2009;27(1):22-7.
2009: Camastra S; Manco M; Frascerra S; Iaconelli A; Mingrone G; Ferrannini E
Daylong pituitary hormones in morbid obesity: effects of bariatric surgery.
International journal of obesity (2005) 2009;33(1):166-72.
2009: Nathan David M; Buse John B; Davidson Mayer B; Ferrannini Ele; Holman Rury R; Sherwin Robert; Zinman Bernard;
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetes care 2009;32(1):193-203.
2009: Nathan D M; Buse J B; Davidson M B; Ferrannini E; Holman R R; Sherwin R; Zinman B;
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetologia 2009;52(1):17-30.
2009: Antonelli Alessandro; Fazzi Piera; Fallahi Poupak; Ferrari Silvia Martina; Grosso Mariano; Boni Giuseppe; Ferrannini Ele; Mariani Giuliano
Thyroid uptake of 67Ga-citrate is associated with thyroid autoimmunity and hypothyroidism in patients with sarcoidosis.
European journal of nuclear medicine and molecular imaging 2009;36(1):137-43.
2008: Antonelli A; Fallahi P; Ferrari S M; Pupilli C; d'Annunzio G; Lorini R; Vanelli M; Ferrannini E
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study.
Diabetic medicine : a journal of the British Diabetic Association 2008;25(11):1349-53.
2008: Antonelli Alessandro; Fallahi Poupak; Delle Sedie Andrea; Ferrari Silvia Martina; Maccheroni Marco; Bombardieri Stefano; Riente Lucrezia; Ferrannini Ele
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis.
Autoimmunity 2008;41(7):537-42.
2008: Mari A; Ferrannini E
Beta-cell function assessment from modelling of oral tests: an effective approach.
Diabetes, obesity & metabolism 2008;10 Suppl 4():77-87.
2008: Giorda Carlo B; Avogaro Angelo; Maggini Marina; Lombardo Flavia; Mannucci Edoardo; Turco Salvatore; Alegiani Stefania Spila; Raschetti Roberto; Velussi Mario; Ferrannini Ele;
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors.
Diabetes care 2008;31(11):2154-9.
2008: Santini E; Lupi R; Baldi S; Madec S; Chimenti D; Ferrannini E; Solini A
Effects of different LDL particles on inflammatory molecules in human mesangial cells.
Diabetologia 2008;51(11):2117-25.
2008: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Ferrari Silvia Martina; Sebastiani Marco; Ferrari Daniela; Giunti Marco; Frascerra Silvia; Tolari Simone; Franzoni Ferdinando; Galetta Fabio; Marchi Santino; Ferrannini Ele
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
The American journal of gastroenterology 2008;103(10):2488-94.
2008: Rosenzweig James L; Ferrannini Ele; Grundy Scott M; Haffner Steven M; Heine Robert J; Horton Edward S; Kawamori Ryuzo;
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline.
The Journal of clinical endocrinology and metabolism 2008;93(10):3671-89.
2008: Balkau Beverley; Mhamdi Leila; Oppert Jean-Michel; Nolan John; Golay Alain; Porcellati Francesca; Laakso Markku; Ferrannini Ele;
Physical activity and insulin sensitivity: the RISC study.
Diabetes 2008;57(10):2613-8.
2008: Antonelli Alessandro; Fallahi Poupak; Tolari Simone; Ferrari Silvia Martina; Ferrannini Ele
Thyroid-associated ophthalmopathy and TSH receptor autoantibodies in nonmetastatic thyroid cancer after total thyroidectomy.
The American journal of the medical sciences 2008;336(3):288-90.
2008: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Colaci Michele; Giuggioli Dilia; Ferrari Silvia Martina; Frascerra Silvia; Franzoni Ferdinando; Galetta Fabio; Ferrannini Ele
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis.
The Journal of rheumatology 2008;35(9):1809-11.
2008: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Ferrari Silvia Martina; Frascerra Silvia; Carpi Angelo; Nicolini Andrea; Ferrannini Ele
Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.
Metabolism: clinical and experimental 2008;57(9):1270-7.
2008: Antonelli Alessandro; Ferrari Silvia Martina; Fallahi Poupak; Berti Piero; Materazzi Gabriele; Marchetti Ivo; Ugolini Clara; Basolo Fulvio; Miccoli Paolo; Ferrannini Ele
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(3):283-91.
2008: Antonelli A; Fallahi P; Rotondi M; Ferrari S M; Romagnani P; Ghiadoni L; Serio M; Taddei S; Ferrannini E
High serum levels of CXC chemokine ligand 10 in untreated essential hypertension.
Journal of human hypertension 2008;22(8):579-81.
2008: Santini E; Madec S; Corretti V; Ferrannini E; Solini A
Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.
Journal of endocrinological investigation 2008;31(7):660-5.
2008: Kozakova Michaela; Muscelli Elza; Flyvbjerg Allan; Frystyk Jan; Morizzo Carmela; Palombo Carlo; Ferrannini Ele
Adiponectin and left ventricular structure and function in healthy adults.
The Journal of clinical endocrinology and metabolism 2008;93(7):2811-8.
2008: Antonelli Alessandro; Ferrari Silvia Martina; Fallahi Poupak; Berti Piero; Materazzi Gabriele; Barani Lucio; Marchetti Ivo; Ferrannini Ele; Miccoli Paolo
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests.
Clinical endocrinology 2008;69(1):148-52.
2008: Slimani Lotfi; Kudomi Nobuyuki; Oikonen Vesa; Jarvisalo M; Kiss Jan; Naum Alexandru; Borra Ronald; Viljanen Antti; Sipila Hannu; Ferrannini Ele; Savunen Timo; Nuutila Pirjo; Iozzo Patricia
Quantification of liver perfusion with [(15)O]H(2)O-PET and its relationship with glucose metabolism and substrate levels.
Journal of hepatology 2008;48(6):974-82.
2008: Natali A; Baldi S; Vittone F; Muscelli E; Casolaro A; Morgantini C; Palombo C; Ferrannini E
Effects of glucose tolerance on the changes provoked by glucose ingestion in microvascular function.
Diabetologia 2008;51(5):862-71.
2008: Muscelli Elza; Mari Andrea; Casolaro Arturo; Camastra Stefania; Seghieri Giuseppe; Gastaldelli Amalia; Holst Jens J; Ferrannini Ele
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
Diabetes 2008;57(5):1340-8.
2008: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Ferrari Silvia Martina; Frascerra Silvia; Sebastiani Marco; Franzoni Ferdinando; Galetta Fabio; Ferrannini Ele
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis.
Cytokine 2008;42(1):137-43.
2008: McGuire Darren K; Winterfield Jeffrey R; Rytlewski Jason A; Ferrannini Ele
Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(1):59-66.
2008: Solini Anna; Santini Eleonora; Madec Stephanie; Nannipieri Monica; Bonotti Alessandra; Cuccato Sabina; Ferrannini Ele
Rosiglitazone increases matrix production and quenches inflammation: studies in human cells.
Diabetes/metabolism research and reviews 2008;24(3):197-204.
2008: Sironi Anna Maria; Pingitore Alessandro; Ghione Sergio; De Marchi Daniele; Scattini Barbara; Positano Vincenzo; Muscelli Elza; Ciociaro Demetrio; Lombardi Massimo; Ferrannini Ele; Gastaldelli Amalia
Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat.
Hypertension 2008;51(2):282-8.
2008: Patel Sheila; Flyvbjerg Allan; Kozàkovà Michaela; Frystyk Jan; Ibrahim Ibrahim M; Petrie John R; Avery Peter J; Ferrannini Ele; Walker Mark;
Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects.
European heart journal 2008;29(3):386-93.
2008: Nathan David M; Buse John B; Davidson Mayer B; Ferrannini Ele; Holman Rury R; Sherwin Robert; Zinman Bernard
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetes care 2008;31(1):173-5.
2008: Antonelli A; Ferri C; Fallahi P; Ferrari S M; Giuggioli D; Colaci M; Manfredi A; Frascerra S; Franzoni F; Galetta F; Ferrannini E
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study.
Rheumatology (Oxford, England) 2008;47(1):45-9.
2008: Schneider Christian A; Ferrannini Ele; Defronzo Ralph; Schernthaner Guntram; Yates John; Erdmann Erland
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2008;19(1):182-7.
2008: Nathan D M; Buse J B; Davidson M B; Ferrannini E; Holman R R; Sherwin R; Zinman B
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.
Diabetologia 2008;51(1):8-11.
2007: Solini Anna; Santini Eleonora; Madec Stephanie; Cuccato Sabina; Ferrannini Ele
Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: Possible role in wound healing and tissue repair.
Growth factors (Chur, Switzerland) 2007;25(6):392-9.
2007: Pascoe Laura; Tura Andrea; Patel Sheila K; Ibrahim Ibrahim M; Ferrannini Ele; Zeggini Eleftheria; Weedon Michael N; Mari Andrea; Hattersley Andrew T; McCarthy Mark I; Frayling Timothy M; Walker Mark;
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.
Diabetes 2007;56(12):3101-4.
2007: Nannipieri M; Bonotti A; Anselmino M; Cecchetti F; Madec S; Mancini E; Baldi S; Santini F; Pinchera A; Rossi M; Ferrannini E
Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state.
International journal of obesity (2005) 2007;31(12):1843-8.
2007: Efendic Suad; Boitard Christian; Ferrannini Ele; Henquin Jean-Claude; Steiner Donald F; Cerasi Erol
Of mighty mice and diabetic men: animal models of islet dysfunction.
Diabetes, obesity & metabolism 2007;9 Suppl 2():1-4.
2007: Ferrannini E; Muscelli E; Natali A; Gabriel R; Mitrakou A; Flyvbjerg A; Golay A; Hojlund K;
Association of fasting glucagon and proinsulin concentrations with insulin resistance.
Diabetologia 2007;50(11):2342-7.
2007: Seghieri G; Tesi F; Anichini R; De Bellis A; Barsotti E; Mari A; Ferrannini E
Influence of gestational diabetes on the long-term control of glucose tolerance.
Diabetologia 2007;50(11):2234-8.
2007: Femia Romana; Kozakova Michaela; Nannipieri Monica; Gonzales-Villalpando Clicerio; Stern Michael P; Haffner Steven M; Ferrannini Ele
Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(10):2244-9.
2007: Gastaldelli Amalia; Cusi Kenneth; Pettiti Maura; Hardies Jean; Miyazaki Yoshinori; Berria Rachele; Buzzigoli Emma; Sironi Anna Maria; Cersosimo Eugenio; Ferrannini Ele; Defronzo Ralph A
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastroenterology 2007;133(2):496-506.
2007: Ferrannini Ele; Balkau Beverley; Coppack Simon W; Dekker Jacqueline M; Mari Andrea; Nolan John; Walker Mark; Natali Andrea; Beck-Nielsen Henning;
Insulin resistance, insulin response, and obesity as indicators of metabolic risk.
The Journal of clinical endocrinology and metabolism 2007;92(8):2885-92.
2007: Mari Andrea; Degn Kristine; Brock Birgitte; Rungby Joergen; Ferrannini Ele; Schmitz Ole
Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions.
Diabetes care 2007;30(8):2032-3.
2007: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Pampana Alessandro; Ferrari Silvia Martina; Barani Lucio; Marchi Santino; Ferrannini Ele
Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study.
Thyroid : official journal of the American Thyroid Association 2007;17(5):447-51.
2007: Avogaro Angelo; Giorda Carlo; Maggini Marina; Mannucci Edoardo; Raschetti Roberto; Lombardo Flavia; Spila-Alegiani Stefania; Turco Salvatore; Velussi Mario; Ferrannini Ele;
Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
Diabetes care 2007;30(5):1241-7.
2007: Solini Anna; Santini Eleonora; Chimenti Daniele; Chiozzi Paola; Pratesi Federico; Cuccato Sabina; Falzoni Simonetta; Lupi Roberto; Ferrannini Ele; Pugliese Giuseppe; Di Virgilio Francesco
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4.
American journal of physiology. Renal physiology 2007;292(5):F1537-47.
2007: Camastra Stefania; Manco Melania; Mari Andrea; Greco Aldo V; Frascerra Silvia; Mingrone Geltrude; Ferrannini Ele
Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery.
Diabetes care 2007;30(4):1002-4.
2007: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Cazzato Massimiliano; Ferrari Silvia Martina; Sebastiani Marco; Ferrannini Ele
Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis.
European journal of endocrinology / European Federation of Endocrine Societies 2007;156(4):431-7.
2007: Giorda Carlo Bruno; Avogaro Angelo; Maggini Marina; Lombardo Flavia; Mannucci Edoardo; Turco Salvatore; Alegiani Stefania Spila; Raschetti Roberto; Velussi Mario; Ferrannini Ele;
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study.
Stroke; a journal of cerebral circulation 2007;38(4):1154-60.
2007: Baldi Simona; Frascerra Silvia; Ferrannini Ele; Natali Andrea
LDL resistance to oxidation: effects of lipid phenotype, autologous HDL and alanine.
Clinica chimica acta; international journal of clinical chemistry 2007;379(1-2):95-100.
2007: Antonelli Alessandro; Rotondi Mario; Fallahi Poupak; Grosso Mariano; Boni Giuseppe; Ferrari Silvia Martina; Romagnani Paola; Serio Mario; Mariani Giuliano; Ferrannini Ele
Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter.
The Journal of clinical endocrinology and metabolism 2007;92(4):1485-90.
2007: Guiducci Letizia; Grönroos Tove; Järvisalo Mikko J; Kiss Jan; Viljanen Antti; Naum Alexandru G; Viljanen Tapio; Savunen Timo; Knuuti Juhani; Ferrannini Ele; Salvadori Piero A; Nuutila Pirjo; Iozzo Patricia
Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(3):455-62.
2007: Gastaldelli Amalia; Ferrannini Ele; Miyazaki Yoshinori; Matsuda Masafumi; Mari Andrea; DeFronzo Ralph A
Thiazolidinediones improve beta-cell function in type 2 diabetic patients.
American journal of physiology. Endocrinology and metabolism 2007;292(3):E871-83.
2007: Ferrannini Ele
Metabolic syndrome: a solution in search of a problem.
The Journal of clinical endocrinology and metabolism 2007;92(2):396-8.
2007: Gastaldelli A; Casolaro A; Pettiti M; Nannipieri M; Ciociaro D; Frascerra S; Buzzigoli E; Baldi S; Mari A; Ferrannini E
Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.
Clinical pharmacology and therapeutics 2007;81(2):205-12.
2007: Iozzo Patricia; Jarvisalo Mikko J; Kiss Jan; Borra Ronald; Naum Gratian A; Viljanen Antti; Viljanen Tapio; Gastaldelli Amalia; Buzzigoli Emma; Guiducci Letizia; Barsotti Elisabetta; Savunen Timo; Knuuti Juhani; Haaparanta-Solin Merja; Ferrannini Ele; Nuutila Pirjo
Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.
Gastroenterology 2007;132(2):531-42.
2006: Ferrannini Ele
Keep an eye on diabetes.
Nature clinical practice. Endocrinology & metabolism 2006;2(12):649.
2006: Taddei Stefano; Caraccio Nadia; Virdis Agostino; Dardano Angela; Versari Daniele; Ghiadoni Lorenzo; Ferrannini Ele; Salvetti Antonio; Monzani Fabio
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis.
The Journal of clinical endocrinology and metabolism 2006;91(12):5076-82.
2006: Muscelli Elza; Mari Andrea; Natali Andrea; Astiarraga Brenno D; Camastra Stefania; Frascerra Silvia; Holst Jens J; Ferrannini Ele
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
American journal of physiology. Endocrinology and metabolism 2006;291(6):E1144-50.
2006: Nannipieri Monica; Posadas Rosalinda; Bonotti Alessandra; Williams Ken; Gonzalez-Villalpando Clicerio; Stern Michael P; Ferrannini Ele
Polymorphism of the 3'-untranslated region of the leptin receptor gene, but not the adiponectin SNP45 polymorphism, predicts type 2 diabetes: a population-based study.
Diabetes care 2006;29(11):2509-11.
2006: Kankaanpää Mikko; Lehto Hanna-Riikka; Pärkkä Jussi P; Komu Markku; Viljanen Antti; Ferrannini Ele; Knuuti Juhani; Nuutila Pirjo; Parkkola Riitta; Iozzo Patricia
Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels.
The Journal of clinical endocrinology and metabolism 2006;91(11):4689-95.
2006: Basta Giuseppina; Sironi Anna Maria; Lazzerini Guido; Del Turco Serena; Buzzigoli Emma; Casolaro Arturo; Natali Andrea; Ferrannini Ele; Gastaldelli Amalia
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
The Journal of clinical endocrinology and metabolism 2006;91(11):4628-34.
2006: Antonelli Alessandro; Delle Sedie Andrea; Fallahi Poupak; Ferrari Silvia Martina; Maccheroni Marco; Ferrannini Ele; Bombardieri Stefano; Riente Lucrezia
High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis.
The Journal of rheumatology 2006;33(10):2026-8.
2006: Gastaldelli Amalia; Miyazaki Yoshinori; Mahankali Archana; Berria Rachele; Pettiti Maura; Buzzigoli Emma; Ferrannini Eleuterio; DeFronzo Ralph A
The effect of pioglitazone on the liver: role of adiponectin.
Diabetes care 2006;29(10):2275-81.
2006: Solini A; Santini E; Nannipieri M; Ferrannini E
High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts.
Diabetologia 2006;49(10):2499-506.
2006: Dardano Angela; Ghiadoni Lorenzo; Plantinga Yvonne; Caraccio Nadia; Bemi Alessia; Duranti Emiliano; Taddei Stefano; Ferrannini Ele; Salvetti Antonio; Monzani Fabio
Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2006;91(10):4175-8.
2006: Manco Melania; Nolfe Giuseppe; Calvani Menotti; Natali Andrea; Nolan John; Ferrannini Eleuterio; Mingrone Geltrude;
Menopause, insulin resistance, and risk factors for cardiovascular disease.
Menopause (New York, N.Y.) 2006;13(5):809-17.
2006: Antonelli Alessandro; Fazzi Piera; Fallahi Poupak; Ferrari Silvia Martina; Ferrannini Ele
Prevalence of hypothyroidism and Graves disease in sarcoidosis.
Chest 2006;130(2):526-32.
2006: Ferrannini Ele; Iozzo Patricia
Is insulin resistance atherogenic? A review of the evidence.
Atherosclerosis. Supplements 2006;7(4):5-10.
2006: Solini A; Santini E; Ferrannini E
Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects.
International journal of obesity (2005) 2006;30(8):1197-202.
2006: Ruige Johannes B; Mertens Ilse L; Bartholomeeusen Ellen; Dirinck Eveline; Ferrannini Ele; Van Gaal Luc F
Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal.
Obesity (Silver Spring, Md.) 2006;14(7):1250-6.
2006: Femia Romana; Natali Andrea; L'Abbate Antonio; Ferrannini Ele
Coronary atherosclerosis and alcohol consumption: angiographic and mortality data.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(7):1607-12.
2006: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Ferrari Silvia Martina; Ghinoi Alessandra; Rotondi Mario; Ferrannini Ele
Thyroid disorders in chronic hepatitis C virus infection.
Thyroid : official journal of the American Thyroid Association 2006;16(6):563-72.
2006: Iozzo Patricia; Gastaldelli Amalia; Järvisalo Mikko J; Kiss Jan; Borra Ronald; Buzzigoli Emma; Viljanen Antti; Naum G; Viljanen Tapio; Oikonen Vesa; Knuuti Juhani; Savunen Timo; Salvadori Piero A; Ferrannini Ele; Nuutila Pirjo
18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):1016-22.
2006: Guiducci Letizia; Järvisalo Mikko; Kiss Jan; Någren Kjell; Viljanen Antti; Naum Alexandru G; Gastaldelli Amalia; Savunen Timo; Knuuti Juhani; Salvadori Piero A; Ferrannini Ele; Nuutila Pirjo; Iozzo Patricia
[11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia.
Nuclear medicine and biology 2006;33(4):521-8.
2006: Antonelli Alessandro; Fallahi Poupak; Rotondi Mario; Ferrari Silvia Martina; Romagnani Paola; Grosso Mariano; Ferrannini Ele; Serio Mario
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process.
European journal of endocrinology / European Federation of Endocrine Societies 2006;154(5):651-8.
2006: Antonelli Alessandro; Rotondi Mario; Fallahi Poupak; Ferrari Silvia Martina; Paolicchi Aldo; Romagnani Paola; Serio Mario; Ferrannini Ele
Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing.
Cytokine 2006;34(1-2):32-8.
2006: Natali Andrea; Toschi Elena; Baldeweg Stephanie; Ciociaro Demetrio; Favilla Stefania; Saccà Luigi; Ferrannini Ele
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.
Diabetes 2006;55(4):1133-40.
2006: Solini A; Zamboni P; Passaro A; Fellin R; Ferrannini E
Acute vascular events and electrolytes variations in elderly patients.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2006;38(3):197-202.
2006: Natali A; Ferrannini E
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review.
Diabetologia 2006;49(3):434-41.
2006: Gastaldelli Amalia; Miyazaki Yoshinori; Pettiti Maura; Santini Eleonora; Ciociaro Demetrio; Defronzo Ralph A; Ferrannini Ele
The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2006;91(3):806-12.
2006: Antonelli Alessandro; Rotondi Mario; Fallahi Poupak; Romagnani Paola; Ferrari Silvia Martina; Barani Lucio; Ferrannini Ele; Serio Mario
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Clinical endocrinology 2006;64(2):189-95.
2006: Antonelli Alessandro; Rotondi Mario; Ferrari Silvia Martina; Fallahi Poupak; Romagnani Paola; Franceschini Stefano Sellari; Serio Mario; Ferrannini Ele
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
The Journal of clinical endocrinology and metabolism 2006;91(2):614-20.
2006: Halban Philippe A; Ferrannini Ele; Nerup Jørn
Diabetes research investment in the European Union.
Nature medicine 2006;12(1):70-2.
2006: Ferrannini Ele
Is insulin resistance the cause of the metabolic syndrome?
Annals of medicine 2006;38(1):42-51.
2005: Kahn Richard; Buse John; Ferrannini Ele; Stern Michael
The metabolic syndrome.
Lancet 2005;366(9501):1921-2; author reply 1923-4.
2005: Boitard Christian; Efendic Suad; Ferrannini Ele; Henquin Jean-Claude; Steiner Donald F; Cerasi Erol
A tale of two cousins: type 1 and type 2 diabetes.
Diabetes 2005;54 Suppl 2():S1-3.
2005: Walker M; Mari A; Jayapaul M K; Bennett S M A; Ferrannini E
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.
Diabetologia 2005;48(12):2470-6.
2005: Viljanen Antti P M; Virtanen Kirsi A; Järvisalo Mikko J; Hällsten Kirsti; Parkkola Riitta; Rönnemaa Tapani; Lönnqvist Fredrik; Iozzo Patricia; Ferrannini Ele; Nuutila Pirjo
Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin.
The Journal of clinical endocrinology and metabolism 2005;90(12):6523-8.
2005: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Pampana Alessandro; Ferrari Silvia Martina; Goglia Fernando; Ferrannini Ele
Hepatitis C virus infection: evidence for an association with type 2 diabetes.
Diabetes care 2005;28(10):2548-50.
2005: Gastaldelli A; Sironi A M; Ciociaro D; Positano V; Buzzigoli E; Giannessi D; Lombardi M; Mari A; Ferrannini E
Visceral fat and beta cell function in non-diabetic humans.
Diabetologia 2005;48(10):2090-6.
2005: Antonelli Alessandro; Rotondi Mario; Fallahi Poupak; Romagnani Paola; Ferrari Silvia Martina; Ferrannini Ele; Serio Mario
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2005;25(9):547-52.
2005: Kahn Richard; Buse John; Ferrannini Ele; Stern Michael;
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetes care 2005;28(9):2289-304.
2005: Virtanen Kirsi A; Iozzo Patricia; Hällsten Kirsti; Huupponen Risto; Parkkola Riitta; Janatuinen Tuula; Lönnqvist Fredrik; Viljanen Tapio; Rönnemaa Tapani; Lönnroth Peter; Knuuti Juhani; Ferrannini Ele; Nuutila Pirjo
Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study.
Diabetes 2005;54(9):2720-6.
2005: Kahn R; Buse J; Ferrannini E; Stern M
The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetologia 2005;48(9):1684-99.
2005: Camastra Stefania; Manco Melania; Mari Andrea; Baldi Simona; Gastaldelli Amalia; Greco Aldo V; Mingrone Gertrude; Ferrannini Ele
beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss.
Diabetes 2005;54(8):2382-9.
2005: Mingrone Geltrude; Manco Melania; Granato Luigi; Calvani Menotti; Scarfone Antonio; Mora Elena Valera; Greco Aldo V; Vidal Hubert; Castagneto Marco; Ferrannini Eleuterio
Leptin pulsatility in formerly obese women.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(10):1380-2.
2005: Antonelli Alessandro; Ferri Clodoveo; Fallahi Poupak; Ferrari Silvia Martina; Ghinoi Alessandra; Mascia Maria Teresa; Ferrannini Ele
[Extrahepatic manifestations of hepatitis C virus: the thyroid disorders]
Recenti progressi in medicina 2005;96(7-8):370-81.
2005: Nannipieri Monica; Gonzales Clicerio; Baldi Simona; Posadas Rosalinda; Williams Ken; Haffner Steven M; Stern Michael P; Ferrannini Ele;
Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.
Diabetes care 2005;28(7):1757-62.
2005: Caraccio Nadia; Natali Andrea; Sironi Annamaria; Baldi Simona; Frascerra Silvia; Dardano Angela; Monzani Fabio; Ferrannini Ele
Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial of levothyroxine.
The Journal of clinical endocrinology and metabolism 2005;90(7):4057-62.
2005: Caraccio N; Dardano A; Manfredonia F; Manca L; Pasquali L; Iudice A; Murri L; Ferrannini E; Monzani F
Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration.
The Journal of clinical endocrinology and metabolism 2005;90(7):4133-7.
2005: Caraccio Nadia; Monzani Fabio; Santini Eleonora; Cuccato Sabina; Ferrari Davide; Callegari Maria Giulia; Gulinelli Sara; Pizzirani Cinzia; Di Virgilio Francesco; Ferrannini Ele; Solini Anna
Extracellular adenosine 5'-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors.
Endocrinology 2005;146(7):3172-8.
2005: Valera-Mora Maria E; Simeoni Benedetta; Gagliardi Lucilla; Scarfone Antonino; Nanni Giuseppe; Castagneto Marco; Manco Melania; Mingrone Geltrude; Ferrannini Ele
Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery.
The American journal of clinical nutrition 2005;81(6):1292-7.
2005: Mari Andrea; Gastaldelli Amalia; Foley James E; Pratley Richard E; Ferrannini Ele
Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.
Diabetes care 2005;28(5):1132-8.
2005: Kozakova Michaela; Fraser Alan G; Buralli Simona; Magagna Armando; Salvetti Antonio; Ferrannini Ele; Palombo Carlo
Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest.
Hypertension 2005;45(4):619-24.
2005: Natali Andrea; Toschi Elena; Baldeweg Stephanie; Casolaro Arturo; Baldi Simona; Sironi Anna Maria; Yudkin John S; Ferrannini Ele
Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels.
European heart journal 2005;26(5):464-71.
2005: Ferrannini Ele
Insulin and blood pressure: connected on a circumference?
Hypertension 2005;45(3):347-8.
2005: Mari Andrea; Gastaldelli Amalia; Natali Andrea; Ostergard Torben; Schmitz Ole; Ferrannini Ele
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
American journal of physiology. Endocrinology and metabolism 2005;288(3):E541-6.
2005: Antonelli Alessandro; Rotondi Mario; Fallahi Poupak; Romagnani Paola; Ferrari Silvia Martina; Paolicchi Aldo; Ferrannini Ele; Serio Mario
Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(2):171-7.
2005: Stern Steven E; Williams Ken; Ferrannini Eleuterio; DeFronzo Ralph A; Bogardus Clifton; Stern Michael P
Identification of individuals with insulin resistance using routine clinical measurements.
Diabetes 2005;54(2):333-9.
2005: Solini Anna; Santini Eleonora; Ferrannini Ele
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemia.
Journal of hypertension 2005;23(2):367-74.
2005: Brunner Hanspeter; Cockcroft John R; Deanfield John; Donald Ann; Ferrannini Ele; Halcox Julian; Kiowski Wolfgang; Lüscher Thomas F; Mancia Giuseppe; Natali Andrea; Oliver James J; Pessina Achille C; Rizzoni Damiano; Rossi Gian Paolo; Salvetti Antonio; Spieker Lukas E; Taddei Stefano; Webb David J;
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.
Journal of hypertension 2005;23(2):233-46.
2005: Caraccio N; Giannini R; Cuccato S; Faviana P; Berti P; Galleri D; Dardano A; Basolo F; Ferrannini E; Monzani F
Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures.
The Journal of clinical endocrinology and metabolism 2005;90(2):1156-62.
2005: Muscelli Elza; Mingrone Gertrude; Camastra Stefania; Manco Melania; Pereira Juliano Alves; Pareja José Carlos; Ferrannini Ele
Differential effect of weight loss on insulin resistance in surgically treated obese patients.
The American journal of medicine 2005;118(1):51-7.
2005: Ferrannini E
Rosiglitazone and lipid metabolism.
Diabetologia 2005;48(1):6-7.
2005: Ferrannini Ele; Gastaldelli Amalia; Miyazaki Yoshinori; Matsuda Masafumi; Mari Andrea; DeFronzo Ralph A
beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.
The Journal of clinical endocrinology and metabolism 2005;90(1):493-500.
2004: Santini Eleonora; Fallahi Poupak; Ferrari Silvia Martina; Masoni Antonio; Antonelli Alessandro; Ferrannini Ele
Effect of PPAR-gamma activation and inhibition on glucose-stimulated insulin release in INS-1e cells.
Diabetes 2004;53 Suppl 3():S79-83.
2004: Ferrannini Ele; Camastra Stefania; Gastaldelli Amalia; Maria Sironi Anna; Natali Andrea; Muscelli Elza; Mingrone Geltrude; Mari Andrea
beta-cell function in obesity: effects of weight loss.
Diabetes 2004;53 Suppl 3():S26-33.
2004: Henquin Jean-Claude; Boitard Christian; Cerasi Erol; Ferrannini Ele; Steiner Donald F; Efendic Suad
Impact of treatment on islet function in type 2 diabetes.
Diabetes 2004;53 Suppl 3():S1-5.
2004: Antonelli Alessandro; Rotondi Mario; Fallahi Poupak; Romagnani Paola; Ferrari Silvia Martina; Buonamano Andrea; Ferrannini Ele; Serio Mario
High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism.
The Journal of clinical endocrinology and metabolism 2004;89(11):5496-9.
2004: Iozzo Patricia; Takala Teemu; Oikonen Vesa; Bergman Jörgen; Grönroos Tove; Ferrannini Ele; Nuutila Pirjo; Knuuti Juhani
Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia.
Diabetes care 2004;27(9):2172-7.
2004: Gastaldelli Amalia; Miyazaki Yoshinori; Pettiti Maura; Buzzigoli Emma; Mahankali Srikanth; Ferrannini Ele; DeFronzo Ralph A
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis.
The Journal of clinical endocrinology and metabolism 2004;89(8):3914-21.
2004: Sironi Anna Maria; Gastaldelli Amalia; Mari Andrea; Ciociaro Demetrio; Positano Vincenzo; Buzzigoli Emma; Ghione Sergio; Turchi Stefano; Lombardi Massimo; Ferrannini Ele
Visceral fat in hypertension: influence on insulin resistance and beta-cell function.
Hypertension 2004;44(2):127-33.
2004: Antonelli A; Ferri C; Fallahi P; Giuggioli D; Nesti C; Longombardo G; Fadda P; Pampana A; Maccheroni M; Ferrannini E
Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia.
QJM : monthly journal of the Association of Physicians 2004;97(8):499-506.
2004: Antonelli A; Ferrannini E
CD38 autoimmunity: recent advances and relevance to human diabetes.
Journal of endocrinological investigation 2004;27(7):695-707.
2004: Iozzo P; Lautamaki R; Geisler F; Virtanen K A; Oikonen V; Haaparanta M; Yki-Jarvinen H; Ferrannini E; Knuuti J; Nuutila P
Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.
Diabetologia 2004;47(7):1149-56.
2004: Iozzo Patricia; Turpeinen Anu K; Takala Teemu; Oikonen Vesa; Bergman Jörgen; Grönroos Tove; Ferrannini Ele; Nuutila Pirjo; Knuuti Juhani
Defective liver disposal of free fatty acids in patients with impaired glucose tolerance.
The Journal of clinical endocrinology and metabolism 2004;89(7):3496-502.
2004: Antonelli Alessandro; Ferri Clodoveo; Pampana Alessandro; Fallahi Poupak; Nesti Claudia; Pasquini Martina; Marchi Santino; Ferrannini Ele
Thyroid disorders in chronic hepatitis C.
The American journal of medicine 2004;117(1):10-3.
2004: Solini A; Passaro A; Fioretto P; Nannipieri M; Ferrannini E
Lipoprotein lipase gene variants and progression of nephropathy in hypercholesterolaemic patients with type 2 diabetes.
Journal of internal medicine 2004;256(1):30-6.
2004: Natali Andrea; Baldeweg Stephanie; Toschi Elena; Capaldo Brunella; Barbaro Daniele; Gastaldelli Amalia; Yudkin John S; Ferrannini Ele
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.
Diabetes care 2004;27(6):1349-57.
2004: Natali Andrea; Ferrannini Ele
Hypertension, insulin resistance, and the metabolic syndrome.
Endocrinology and metabolism clinics of North America 2004;33(2):417-29.
2004: Monzani F; Caraccio N; Kozàkowà M; Dardano A; Vittone F; Virdis A; Taddei S; Palombo C; Ferrannini E
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study.
The Journal of clinical endocrinology and metabolism 2004;89(5):2099-106.
2004: Ferrannini E; Mari A
Beta cell function and its relation to insulin action in humans: a critical appraisal.
Diabetologia 2004;47(5):943-56.
2004: Monzani F; Caraccio N; Dardano A; Ferrannini E
Thyroid autoimmunity and dysfunction associated with type I interferon therapy.
Clinical and experimental medicine 2004;3(4):199-210.
2004: Lazarin Mary A C T; Bennini João R; Pereira Carlos L C; Astiarraga Brenno D; Ferrannini Ele; Muscelli Elza
Normal insulin sensitivity in lean offspring of obese parents.
Obesity research 2004;12(4):621-6.
2004: Hills S A; Balkau B; Coppack S W; Dekker J M; Mari A; Natali A; Walker M; Ferrannini E;
The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives.
Diabetologia 2004;47(3):566-70.
2004: Franzoni Ferdinando; Galetta Fabio; Morizzo Carmela; Lubrano Valter; Palombo Carlo; Santoro Gino; Ferrannini Eleuterio; Quiñones-Galvan Alfredo
Effects of age and physical fitness on microcirculatory function.
Clinical science (London, England : 1979) 2004;106(3):329-35.
2004: Boitard Christian; Cerasi Erol; Efendic Suad; Henquin Jean-Claude; Steiner Donald F; Ferrannini Ele
Novel factors in the regulation of beta-cell function.
Diabetes 2004;53 Suppl 1():S1-3.
2004: Antonelli A; Ferri C; Fallahi P; Sebastiani M; Nesti C; Barani L; Barale R; Ferrannini E
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients.
Rheumatology (Oxford, England) 2004;43(2):238-40.
2004: Ferrannini Ele; Nannipieri Monica; Williams Ken; Gonzales Clicerio; Haffner Steve M; Stern Michael P
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance.
Diabetes 2004;53(1):160-5.
2004: Gastaldelli A; Ferrannini E; Miyazaki Y; Matsuda M; DeFronzo R A;
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.
Diabetologia 2004;47(1):31-9.
2003: Ferrannini Ele; Tuomilehto Jaakko
Dyslipidaemia versus endothelial dysfunction: which is more important in the development of vascular disease?
International journal of clinical practice. Supplement 2003;(137):5-14.
2003: Kozàkovà Michaela; Ferrannini Ele; Palombo Carlo
Relation between left ventricular midwall function and coronary vasodilator capacity in arterial hypertension.
Hypertension 2003;42(4):528-33.
2003: Ferrannini Ele
Analysis of data on insulin resistance from the European group for the study of insulin resistance: focus on obesity and hypertension.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2003;9 Suppl 2():43-9.
2003: Ferrannini E; Gastaldelli A; Miyazaki Y; Matsuda M; Pettiti M; Natali A; Mari A; DeFronzo R A
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance.
Diabetologia 2003;46(9):1211-9.
2003: Franzoni Ferdinando; Quiñones-Galvan Alfredo; Regoli Francesco; Ferrannini Ele; Galetta Fabio
A comparative study of the in vitro antioxidant activity of statins.
International journal of cardiology 2003;90(2-3):317-21.
2003: Taddei Stefano; Caraccio Nadia; Virdis Agostino; Dardano Angela; Versari Daniele; Ghiadoni Lorenzo; Salvetti Antonio; Ferrannini Ele; Monzani Fabio
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.
The Journal of clinical endocrinology and metabolism 2003;88(8):3731-7.
2003: Ferrannini Ele; Kozàkovà Michaela
Metabolic effects of antihypertensive treatment: long live the debate.
Journal of hypertension 2003;21(8):1459-62.
2003: Iozzo Patricia; Turpeinen Anu K; Takala Teemu; Oikonen Vesa; Solin Olof; Ferrannini Ele; Nuutila Pirjo; Knuuti Juhani
Liver uptake of free fatty acids in vivo in humans as determined with 14( R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET.
European journal of nuclear medicine and molecular imaging 2003;30(8):1160-4.
2003: Ferrannini Ele; Gastaldelli Amalia; Matsuda Masafumi; Miyazaki Yoshinori; Pettiti Maura; Glass Leonard; DeFronzo Ralph A
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis.
The Journal of clinical endocrinology and metabolism 2003;88(7):3251-7.
2003: Iozzo Patricia; Hallsten Kirsti; Oikonen Vesa; Virtanen Kirsi A; Parkkola Riitta; Kemppainen Jukka; Solin Olof; Lonnqvist Fredrik; Ferrannini Ele; Knuuti Juhani; Nuutila Pirjo
Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.
Diabetes care 2003;26(7):2069-74.
2003: Kozàkovà Michaela; Morizzo Carmela; Ferrannini Ele; Palombo Carlo
Coronary vasodilator capacity and exercise-induced myocardial ischemia are related to the pulsatile component of blood pressure in patients with essential hypertension.
Journal of hypertension 2003;21(7):1407-14.
2003: Antonelli Alessandro; Miccoli Paolo; Fallahi Poupak; Grosso Mariano; Nesti Claudia; Spinelli Claudio; Ferrannini Ele
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer.
Thyroid : official journal of the American Thyroid Association 2003;13(5):479-84.
2003: Iozzo Patricia; Geisler Fabian; Oikonen Vesa; Mäki Maija; Takala Teemu; Solin Olof; Ferrannini Ele; Knuuti Juhani; Nuutila Pirjo;
Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):682-9.
2003: Iozzo Patricia; Hallsten Kirsti; Oikonen Vesa; Virtanen Kirsi A; Kemppainen Jukka; Solin Olof; Ferrannini Ele; Knuuti Juhani; Nuutila Pirjo
Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.
The Journal of clinical endocrinology and metabolism 2003;88(5):2055-60.
2003: Natali Andrea; L'Abbate Antonio; Ferrannini Ele
Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality.
European heart journal 2003;24(7):639-48.
2003: Nannipieri M; Posadas R; Williams K; Politi E; Gonzales-Villalpando C; Stern M P; Ferrannini E
Association between polymorphisms of the atrial natriuretic peptide gene and proteinuria: a population-based study.
Diabetologia 2003;46(3):429-32.
2002: Marchetti Piero; Antonelli Alessandro; Lupi Roberto; Marselli Lorella; Fallahi Poupak; Nesti Claudia; Baj Germano; Ferrannini Ele
Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic islets.
Diabetes 2002;51 Suppl 3():S474-7.
2002: Quiñones-Galvan Alfredo; Pucciarelli Antonio; Ciociaro Demetrio; Masoni Antonio; Franzoni Ferdinando; Natali Andrea; Ferrannini Ele
Metabolic effects of combined antihypertensive treatment in patients with essential hypertension.
Journal of cardiovascular pharmacology 2002;40(6):916-21.
2002: Mari Andrea; Schmitz Ole; Gastaldelli Amalia; Oestergaard Torben; Nyholm Birgit; Ferrannini Ele
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.
American journal of physiology. Endocrinology and metabolism 2002;283(6):E1159-66.
2002: Gastaldelli Amalia; Miyazaki Yoshinori; Pettiti Maura; Matsuda Masafumi; Mahankali Srihanth; Santini Eleonora; DeFronzo Ralph A; Ferrannini Ele
Metabolic effects of visceral fat accumulation in type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2002;87(11):5098-103.
2002: Iozzo P; Chareonthaitawee P; Rimoldi O; Betteridge D J; Camici P G; Ferrannini E
Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.
Diabetologia 2002;45(10):1404-9.
2002: Iozzo Patricia; Chareonthaitawee Panithaya; Dutka David; Betteridge D John; Ferrannini Ele; Camici Paolo G
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
Diabetes 2002;51(10):3020-4.
2002: Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
Diabetologia 2002;45(9):1298-306.
2002: Ferrannini E; Balkau B
Insulin: in search of a syndrome.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(9):724-9.
2002: Monzani Fabio; Meucci Giuseppe; Caraccio Nadia; Saviozzi Michela; Casolaro Arturo; Moscato Gianluca; Lombardo Francesco; Mosti Serena; Scagnolari Carolina; Bruschi Fabrizio; Antonelli Guido; Ferrannini Ele; Murri Luigi
Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(7):773-81.
2002: Siciliano Gabriele; Monzani Fabio; Manca Maria Laura; Tessa Alessandra; Caraccio Nadia; Tozzi Giulia; Piemonte Fiorella; Mancuso Michelangelo; Santorelli Filippo Maria; Ferrannini Eleuterio; Murri Luigi
Human mitochondrial transcription factor A reduction and mitochondrial dysfunction in Hashimoto's hypothyroid myopathy.
Molecular medicine (Cambridge, Mass.) 2002;8(6):326-33.
2002: Nannipieri M; Seghieri G; Catalano C; Prontera T; Baldi S; Ferrannini E
Defective regulation and action of atrial natriuretic peptide in type 2 diabetes.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2002;34(5):265-70.
2002: Iozzo Patricia; Chareonthaitawee Panithaya; Di Terlizzi Marco; Betteridge D John; Ferrannini Ele; Camici Paolo G
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
American journal of physiology. Endocrinology and metabolism 2002;282(5):E1163-71.
2002: Caraccio Nadia; Ferrannini Ele; Monzani Fabio
Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study.
The Journal of clinical endocrinology and metabolism 2002;87(4):1533-8.
2002: Mari Andrea; Tura Andrea; Gastaldelli Amalia; Ferrannini Ele
Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.
Diabetes 2002;51 Suppl 1():S221-6.
2002: Toschi Elena; Camastra Stefania; Sironi Anna Maria; Masoni Antonio; Gastaldelli Amalia; Mari Andrea; Ferrannini Ele; Natali Andrea
Effect of acute hyperglycemia on insulin secretion in humans.
Diabetes 2002;51 Suppl 1():S130-3.
2002: Henquin Jean-Claude; Boitard Christian; Efendic Suad; Ferrannini Ele; Steiner Donald F; Cerasi Erol
Insulin secretion: movement at all levels.
Diabetes 2002;51 Suppl 1():S1-2.
2002: Greco Aldo V; Mingrone Gertrude; Giancaterini Annalisa; Manco Melania; Morroni Manrico; Cinti Saverio; Granzotto Marnie; Vettor Roberto; Camastra Stefania; Ferrannini Ele
Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion.
Diabetes 2002;51(1):144-51.
2001: Antonelli A; Fallahi P; Nesti C; Pupilli C; Marchetti P; Takasawa S; Okamoto H; Ferrannini E
Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease.
Clinical and experimental immunology 2001;126(3):426-31.
2001: Schumann W C; Gastaldelli A; Chandramouli V; Previs S F; Pettiti M; Ferrannini E; Landau B R
Determination of the enrichment of the hydrogen bound to carbon 5 of glucose on 2H2O administration.
Analytical biochemistry 2001;297(2):195-7.
2001: Quiñones-Galvan A; Pucciarelli A; Fratta-Pasini A; Garbin U; Franzoni F; Galetta F; Natali A; Cominacini L; Ferrannini E
Effective blood pressure treatment improves LDL-cholesterol susceptibility to oxidation in patients with essential hypertension.
Journal of internal medicine 2001;250(4):322-6.
2001: Gastaldelli A; Toschi E; Pettiti M; Frascerra S; Quiñones-Galvan A; Sironi A M; Natali A; Ferrannini E
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.
Diabetes 2001;50(8):1807-12.
2001: Nannipieri M; Manganiello M; Pezzatini A; De Bellis A; Seghieri G; Ferrannini E
Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension.
Hypertension 2001;37(6):1416-22.
2001: Antonelli A; Baj G; Marchetti P; Fallahi P; Surico N; Pupilli C; Malavasi F; Ferrannini E
Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets.
Diabetes 2001;50(5):985-91.
2001: Miyazaki Y; Mahankali A; Matsuda M; Glass L; Mahankali S; Ferrannini E; Cusi K; Mandarino L J; DeFronzo R A
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.
Diabetes care 2001;24(4):710-9.
2001: Monzani F; Di Bello V; Caraccio N; Bertini A; Giorgi D; Giusti C; Ferrannini E
Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study.
The Journal of clinical endocrinology and metabolism 2001;86(3):1110-5.
2001: Quiñones-Galvan A; Ferrannini E
Metabolic effects of glucose-insulin infusions: myocardium and whole body.
Current opinion in clinical nutrition and metabolic care 2001;4(2):157-63.
2001: Toschi E; Camastra S; Mari A; Gastaldelli A; Baldi S; Masoni A; Ferrannini E
A model for assessing insulin secretion and its control under free-living conditions.
Diabetes 2001;50 Suppl 1():S178-9.
2001: Mari A; Camastra S; Toschi E; Giancaterini A; Gastaldelli A; Mingrone G; Ferrannini E
A model for glucose control of insulin secretion during 24 h of free living.
Diabetes 2001;50 Suppl 1():S164-8.
2001: Nannipieri M; Lanfranchi A; Santerini D; Catalano C; Van de Werve G; Ferrannini E
Influence of long-term diabetes on renal glycogen metabolism in the rat.
Nephron 2001;87(1):50-7.
2001: Emdin M; Gastaldelli A; Muscelli E; Macerata A; Natali A; Camastra S; Ferrannini E
Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss.
Circulation 2001;103(4):513-9.
2000: Gastaldelli A; Emdin M; Conforti F; Camastra S; Ferrannini E
Insulin prolongs the QTc interval in humans.
American journal of physiology. Regulatory, integrative and comparative physiology 2000;279(6):R2022-5.
2000: Natali A; Sironi A M; Toschi E; Camastra S; Sanna G; Perissinotto A; Taddei S; Ferrannini E
Effect of vitamin C on forearm blood flow and glucose metabolism in essential hypertension.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(11):2401-6.
2000: Natali A; Toschi E; Camastra S; Gastaldelli A; Groop L; Ferrannini E
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. European Group for the Study of Insulin Resistance (EGIR).
Diabetologia 2000;43(10):1266-72.
2000: Galvan A Q; Galetta F; Natali A; Muscelli E; Sironi A M; Cini G; Camastra S; Ferrannini E
Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans.
Circulation 2000;102(18):2233-8.
2000: Monzani F; Caraccio N; Casolaro A; Lombardo F; Moscato G; Murri L; Ferrannini E; Meucci G
Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful?
Neurology 2000;55(4):549-52.
2000: Gastaldelli A; Baldi S; Pettiti M; Toschi E; Camastra S; Natali A; Landau B R; Ferrannini E
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
Diabetes 2000;49(8):1367-73.
2000: Ferrannini E
Insulin resistance, iron, and the liver.
Lancet 2000;355(9222):2181-2.
2000: Natali A; Vichi S; Landi P; Severi S; L'Abbate A; Ferrannini E
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome.
Diabetologia 2000;43(5):632-41.
2000: Natali A; Gastaldelli A; Camastra S; Sironi A M; Toschi E; Masoni A; Ferrannini E; Mari A
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach.
American journal of physiology. Endocrinology and metabolism 2000;278(5):E794-801.
2000: Natali A; Vichi S; Landi P; Toschi E; Severi S; L'abbate A; Ferrannini E
Coronary artery disease and arterial hypertension: clinical, angiographic and follow-up data.
Journal of internal medicine 2000;247(2):219-30.
1999: Camastra S; Bonora E; Del Prato S; Rett K; Weck M; Ferrannini E
Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance).
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(12):1307-13.
1999: Quiñones-Galvan A; Sironi A M; Baldi S; Galetta F; Garbin U; Fratta-Pasini A; Cominacini L; Ferrannini E
Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(12):2928-32.
1999: Ferrannini E; Galvan A Q; Gastaldelli A; Camastra S; Sironi A M; Toschi E; Baldi S; Frascerra S; Monzani F; Antonelli A; Nannipieri M; Mari A; Seghieri G; Natali A
Insulin: new roles for an ancient hormone.
European journal of clinical investigation 1999;29(10):842-52.
1999: Siciliano G; Renna M; Manca M L; Prontera C; Zucchelli G; Ferrannini E; Murri L
The relationship of plasma catecholamine and lactate during anaerobic threshold exercise in mitochondrial myopathies.
Neuromuscular disorders : NMD 1999;9(6-7):411-6.
1999: Monzani F; Caraccio N; Meucci G; Lombardo F; Moscato G; Casolaro A; Ferdeghini M; Murri L; Ferrannini E
Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis.
European journal of endocrinology / European Federation of Endocrine Societies 1999;141(4):325-31.
1999: Monzani F; Caraccio N; Del Guerra P; Casolaro A; Ferrannini E
Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy.
Clinical endocrinology 1999;51(2):237-42.
1999: Gastaldelli A; Mammoliti R; Muscelli E; Camastra S; Landini L; Ferrannini E; Emdin M
Linear and nonlinear properties of heart rate variability: influence of obesity.
Annals of the New York Academy of Sciences 1999;879():249-54.
1999: Mingrone G; Henriksen F L; Greco A V; Krogh L N; Capristo E; Gastaldelli A; Castagneto M; Ferrannini E; Gasbarrini G; Beck-Nielsen H
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency.
Diabetes 1999;48(6):1258-63.
1999: Capaldo B; Gastaldelli A; Antoniello S; Auletta M; Pardo F; Ciociaro D; Guida R; Ferrannini E; Saccà L
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans.
Diabetes 1999;48(5):958-66.
1999: Iozzo P; Beck-Nielsen H; Laakso M; Smith U; Yki-Järvinen H; Ferrannini E
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance.
The Journal of clinical endocrinology and metabolism 1999;84(3):863-8.
1998: Ferrannini E; Camastra S
Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity.
European journal of clinical investigation 1998;28 Suppl 2():3-6; discussion 6-7.
1998: Ferrannini E; Mari A
How to measure insulin sensitivity.
Journal of hypertension 1998;16(7):895-906.
1998: Muscelli E; Emdin M; Natali A; Pratali L; Camastra S; Gastaldelli A; Baldi S; Carpeggiani C; Ferrannini E
Autonomic and hemodynamic responses to insulin in lean and obese humans.
The Journal of clinical endocrinology and metabolism 1998;83(6):2084-90.
1998: Muscelli E; Camastra S; Gastaldelli A; Natali A; Masoni A; Pecori N; Ferrannini E
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(3):262-7.
1998: Natali A; Quiñones Galvan A; Pecori N; Sanna G; Toschi E; Ferrannini E
Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension.
Hypertension 1998;31(2):632-6.
1998: Natali A; Gastaldelli A; Galvan A Q; Sironi A M; Ciociaro D; Sanna G; Rosenzweig P; Ferrannini E
Effects of acute alpha 2-blockade on insulin action and secretion in humans.
The American journal of physiology 1998;274(1 Pt 1):E57-64.
1998: Cominacini L; Garbin U; Fratta Pasini A; Campagnola M; Davoli A; Foot E; Sighieri G; Sironi A M; Lo Cascio V; Ferrannini E
Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients.
Diabetes 1998;47(1):130-3.
1997: Ferrannini E; Natali A; Capaldo B; Lehtovirta M; Jacob S; Yki-Järvinen H
Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).
Hypertension 1997;30(5):1144-9.
1997: Monzani F; Caraccio N; Siciliano G; Manca L; Murri L; Ferrannini E
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism.
The Journal of clinical endocrinology and metabolism 1997;82(10):3315-8.
1997: Muscelli E; Camastra S; Catalano C; Galvan A Q; Ciociaro D; Baldi S; Ferrannini E
Metabolic and cardiovascular assessment in moderate obesity: effect of weight loss.
The Journal of clinical endocrinology and metabolism 1997;82(9):2937-43.
1997: Sironi A M; Vichi S; Gastaldelli A; Pecori N; Anichini R; Foot E; Seghieri G; Ferrannini E
Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes.
Clinical pharmacology and therapeutics 1997;62(2):194-202.
1997: Natali A; Taddei S; Quiñones Galvan A; Camastra S; Baldi S; Frascerra S; Virdis A; Sudano I; Salvetti A; Ferrannini E
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension.
Circulation 1997;96(3):849-55.
1997: Quiñones-Galvan A; Ferrannini E
Renal effects of insulin in man.
Journal of nephrology 1997;10(4):188-91.
1997: Ferrannini E; Camastra S; Coppack S W; Fliser D; Golay A; Mitrakou A
Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR).
The Proceedings of the Nutrition Society 1997;56(2):753-61.
1997: Catalano C; Muscelli E; Natali A; Mazzoni A; Masoni A; Bernardini B; Seghieri G; Ferrannini E
Reciprocal association between insulin sensitivity and the haematocrit in man.
European journal of clinical investigation 1997;27(7):634-7.
1997: Ferrannini E
Insulin resistance is central to the burden of diabetes.
Diabetes/metabolism reviews 1997;13(2):81-6.
1997: Catalano C; Muscelli E; Quiñones Galvan A; Baldi S; Masoni A; Gibb I; Torffvit O; Seghieri G; Ferrannini E
Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects.
Diabetes 1997;46(5):868-75.
1996: Baldi S; Natali A; Buzzigoli G; Galvan A Q; Sironi A M; Ferrannini E
In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance.
Metabolism: clinical and experimental 1996;45(11):1402-7.
1996: Muscelli E; Camastra S; Masoni A; Baldi S; Sironi A M; Natali A; Ferrannini E
Acute insulin administration does not affect plasma leptin levels in lean or obese subjects.
European journal of clinical investigation 1996;26(10):940-3.
1996: Galvan A Q; Natali A; Baldi S; Frascerra S; Sampietro T; Galetta F; Seghieri G; Ferrannini E
Effect of a reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hypercholesterolemia.
Journal of cardiovascular pharmacology 1996;28(4):595-602.
1996: Ambrogi C; Cardini G; Baldi S B; Cini C C; Buzzigoli G; Quinones-Galvan A; Ferrannini E
Delta-aminolevulinic acid dehydratase and zinc protoporphyrin in very low lead-exposed pets: a community study.
Veterinary and human toxicology 1996;38(5):336-9.
1996: Muscelli E; Natali A; Bianchi S; Bigazzi R; Galvan A Q; Sironi A M; Frascerra S; Ciociaro D; Ferrannini E
Effect of insulin on renal sodium and uric acid handling in essential hypertension.
American journal of hypertension 1996;9(8):746-52.
1996: Galvan A Q; Muscelli E; Catalano C; Natali A; Sanna G; Masoni A; Bernardini B; Barsacchi R; Ferrannini E
Insulin decreases circulating vitamin E levels in humans.
Metabolism: clinical and experimental 1996;45(8):998-1003.
1996: Natali A; Quiñones Galvan A; Arzilli F; Taddei S; Pecori N; Frascerra S; Salvetti A; Ferrannini E
Renovascular hypertension and insulin sensitivity.
European journal of clinical investigation 1996;26(7):556-63.
1996: Bonadonna R C; Del Prato S; Bonora E; Saccomani M P; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo R A
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
Diabetes 1996;45(7):915-25.
1996: Quiønones Galvan A; Natali A; Muscelli E; Ciociaro D; Pecori N; Camici P G; Ferrannini E
Insulin sensitivity in cardiological syndrome X.
Journal of internal medicine 1996;239(3):241-7.
1996: Ferrannini E; Muscelli E; Stern M P; Haffner S M
Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1996;20(1):7-14.
1995: Bianchi S; Bigazzi R; Quiñones Galvan A; Muscelli E; Baldari G; Pecori N; Ciociaro D; Ferrannini E; Natali A
Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.
Hypertension 1995;26(5):789-95.
1995: Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Circulation 1995;92(10):2911-8.
1995: Ferrannini E
Physiological and metabolic consequences of obesity.
Metabolism: clinical and experimental 1995;44(9 Suppl 3):15-7.
1995: Quiñones Galvan A; Natali A; Baldi S; Frascerra S; Sanna G; Ciociaro D; Ferrannini E
Effect of insulin on uric acid excretion in humans.
The American journal of physiology 1995;268(1 Pt 1):E1-5.
1994: Natali A; Bonadonna R; Santoro D; Galvan A Q; Baldi S; Frascerra S; Palombo C; Ghione S; Ferrannini E
Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.
The Journal of clinical investigation 1994;94(4):1570-6.
1994: Bianchi S; Bigazzi R; Valtriani C; Chiapponi I; Sgherri G; Baldari G; Natali A; Ferrannini E; Campese V M
Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.
Hypertension 1994;23(6 Pt 1):681-7.
1994: Barrett E J; Bevilacqua S; DeFronzo R A; Ferrannini E
Glycogen turnover during refeeding in the postabsorptive dog: implications for the estimation of glycogen formation using tracer methods.
Metabolism: clinical and experimental 1994;43(3):285-92.
1994: Yin W; Seghieri G; Boni C; Sanna G; Anichini R; Bartolomei G; Ferrannini E
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 1994;9(1):29-33.
1994: Ferrannini E; Seghieri G; Muscelli E
Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.
Journal of cardiovascular pharmacology 1994;24 Suppl 3():S61-9.
1993: Breschi M C; Seghieri G; Bartolomei G; Gironi A; Baldi S; Ferrannini E
Relation of birthweight to maternal plasma glucose and insulin concentrations during normal pregnancy.
Diabetologia 1993;36(12):1315-21.
1993: Brandi L S; Santoro D; Natali A; Altomonte F; Baldi S; Frascerra S; Ferrannini E
Insulin resistance of stress: sites and mechanisms.
Clinical science (London, England : 1979) 1993;85(5):525-35.
1993: Galvan A Q; Santoro D; Natali A; Sampietro T; Boni C; Masoni A; Buzzigoli G; Ferrannini E
Insulin sensitivity in familial hypercholesterolemia.
Metabolism: clinical and experimental 1993;42(10):1359-64.
1993: Natali A; Quiñones Galvan A; Santoro D; Pecori N; Taddei S; Salvetti A; Ferrannini E
Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man.
Clinical science (London, England : 1979) 1993;85(3):327-35.
1993: Ferrannini E; Natali A; Brandi L S; Bonadonna R; De Kreutzemberg S V; DelPrato S; Santoro D
Metabolic and thermogenic effects of lactate infusion in humans.
The American journal of physiology 1993;265(3 Pt 1):E504-12.
1993: Bonadonna R C; Del Prato S; Saccomani M P; Bonora E; Gulli G; Ferrannini E; Bier D; Cobelli C; DeFronzo R A
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.
The Journal of clinical investigation 1993;92(1):486-94.
1993: Paolisso G; Ferrannini E; D'Amore A; Volpe C; Varricchio M; D'Onofrio F
Effects of physiological plasma insulin levels on glucose turnover parameters in familial hypercholesterolemia.
Atherosclerosis 1993;101(1):111-5.
1993: Natali A; Santoro D; Brandi L S; Faraggiana D; Ciociaro D; Pecori N; Buzzigoli G; Ferrannini E
Effects of acute hypercarnitinemia during increased fatty substrate oxidation in man.
Metabolism: clinical and experimental 1993;42(5):594-600.
1993: Santoro D; Galvan A Q; Natali A; Ferrannini E
Some metabolic aspects of essential hypertension and its treatment.
The American journal of medicine 1993;94(4A):32S-39S.
1993: Ferrannini E; Santoro D; Bonadonna R; Natali A; Parodi O; Camici P G
Metabolic and hemodynamic effects of insulin on human hearts.
The American journal of physiology 1993;264(2 Pt 1):E308-15.
1993: Bonadonna R C; Saccomani M P; Seely L; Zych K S; Ferrannini E; Cobelli C; DeFronzo R A
Glucose transport in human skeletal muscle. The in vivo response to insulin.
Diabetes 1993;42(1):191-8.
1992: Paolisso G; Ferrannini E; Sgambato S; Varricchio M; D'Onofrio F
Hyperinsulinemia in patients with hypercholesterolemia.
The Journal of clinical endocrinology and metabolism 1992;75(6):1409-12.
1992: Ferrannini E
The haemodynamics of obesity: a theoretical analysis.
Journal of hypertension 1992;10(11):1417-23.
1992: Seghieri G; Yin W; Boni C; Sanna G; Anichini R; Bartolomei G; Ferrannini E
Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1992;9(8):732-8.
1992: Brandi L S; Grana M; Mazzanti T; Giunta F; Natali A; Ferrannini E
Energy expenditure and gas exchange measurements in postoperative patients: thermodilution versus indirect calorimetry.
Critical care medicine 1992;20(9):1273-83.
1992: Santoro D; Natali A; Palombo C; Brandi L S; Piatti M; Ghione S; Ferrannini E
Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.
Hypertension 1992;20(2):181-91.
1992: Ferrannini E; Galvan A Q; Santoro D; Natali A
Potassium as a link between insulin and the renin-angiotensin-aldosterone system.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(1):S5-10.
1991: Santoro D; Natali A; Galvan A Q; Masoni A; Gazzetti P; Ferrannini E
Glucose tolerance and insulin secretion in essential hypertension after treatment with an angiotensin converting enzyme inhibitor.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S406-7.
1991: Camici P G; Marraccini P; Lorenzoni R; Buzzigoli G; Pecori N; Perissinotto A; Ferrannini E; L'Abbate A; Marzilli M
Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress.
Journal of the American College of Cardiology 1991;17(7):1461-70.
1991: Camici P; Marraccini P; Lorenzoni R; Ferrannini E; Buzzigoli G; Marzilli M; L'Abbate A
Metabolic markers of stress-induced myocardial ischemia.
Circulation 1991;83(5 Suppl):III8-13.
1991: Natali A; Santoro D; Palombo C; Cerri M; Ghione S; Ferrannini E
Impaired insulin action on skeletal muscle metabolism in essential hypertension.
Hypertension 1991;17(2):170-8.
1991: Groop L C; Saloranta C; Shank M; Bonadonna R C; Ferrannini E; DeFronzo R A
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1991;72(1):96-107.
1990: Ferrannini E; Haffner S M; Stern M P
Insulin sensitivity and hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S169-74.
1990: Brandi L S; Frediani M; Oleggini M; Mosca F; Cerri M; Boni C; Pecori N; Buzzigoli G; Ferrannini E
Insulin resistance after surgery: normalization by insulin treatment.
Clinical science (London, England : 1979) 1990;79(5):443-50.
1990: Ferrannini E; Katz L D; Glickman M G; Defronzo R A
Influence of combined intravenous and oral glucose administration on splanchnic glucose uptake in man.
Clinical physiology (Oxford, England) 1990;10(6):527-38.
1990: Ferrannini E; Lanfranchi A; Rohner-Jeanrenaud F; Manfredini G; Van de Werve G
Influence of long-term diabetes on liver glycogen metabolism in the rat.
Metabolism: clinical and experimental 1990;39(10):1082-8.
1990: Buzzigoli G; Lanzone L; Ciociaro D; Frascerra S; Cerri M; Scandroglio A; Coldani R; Ferrannini E
Characterization of a reversed-phase high-performance liquid chromatographic system for the determination of blood amino acids.
Journal of chromatography 1990;507():85-93.
1990: Natali A; Buzzigoli G; Taddei S; Santoro D; Cerri M; Pedrinelli R; Ferrannini E
Effects of insulin on hemodynamics and metabolism in human forearm.
Diabetes 1990;39(4):490-500.
1990: Bevilacqua S; Buzzigoli G; Bonadonna R; Brandi L S; Oleggini M; Boni C; Geloni M; Ferrannini E
Operation of Randle's cycle in patients with NIDDM.
Diabetes 1990;39(3):383-9.
1990: Ferrannini E; Haffner S M; Stern M P
Essential hypertension: an insulin-resistant state.
Journal of cardiovascular pharmacology 1990;15 Suppl 5():S18-25.
1989: Cobelli C; Saccomani M P; Ferrannini E; Defronzo R A; Gelfand R; Bonadonna R
A compartmental model to quantitate in vivo glucose transport in the human forearm.
The American journal of physiology 1989;257(6 Pt 1):E943-58.
1989: Ferrannini E; Groop L C
Hepatic glucose production in insulin-resistant states.
Diabetes/metabolism reviews 1989;5(8):711-26.
1989: Camici P; Ferrannini E; Opie L H
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography.
Progress in cardiovascular diseases 1989;32(3):217-38.
1989: Bonadonna R C; Zych K; Boni C; Ferrannini E; DeFronzo R A
Time dependence of the interaction between lipid and glucose in humans.
The American journal of physiology 1989;257(1 Pt 1):E49-56.
1989: Groop L C; Bonadonna R C; DelPrato S; Ratheiser K; Zyck K; Ferrannini E; DeFronzo R A
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
The Journal of clinical investigation 1989;84(1):205-13.
1989: Ferrannini E; Locatelli L; Jequier E; Felber J P
Differential effects of insulin and hyperglycemia on intracellular glucose disposition in humans.
Metabolism: clinical and experimental 1989;38(5):459-65.
1989: DeFronzo R A; Ferrannini E; Simonson D C
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.
Metabolism: clinical and experimental 1989;38(4):387-95.
1989: Ferrannini E; Natali A; Cerri M; Santoro D; Palombo C
Hypertension: a metabolic disorder?
Diabète & métabolisme 1989;15(5 Pt 2):284-91.
1988: Ferrannini E; Buzzigoli G; Bevilacqua S; Boni C; Del Chiaro D; Oleggini M; Brandi L; Maccari F
Interaction of carnitine with insulin-stimulated glucose metabolism in humans.
The American journal of physiology 1988;255(6 Pt 1):E946-52.
1988: Ferrannini E; Taddei S; Santoro D; Natali A; Boni C; Del Chiaro D; Buzzigoli G
Independent stimulation of glucose metabolism and Na+-K+ exchange by insulin in the human forearm.
The American journal of physiology 1988;255(6 Pt 1):E953-8.
1988: Luzi L; Barrett E J; Groop L C; Ferrannini E; DeFronzo R A
Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis.
Diabetes 1988;37(11):1470-7.
1988: Golay A; DeFronzo R A; Ferrannini E; Simonson D C; Thorin D; Acheson K; Thiébaud D; Curchod B; Jéquier E; Felber J P
Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.
Diabetologia 1988;31(8):585-91.
1988: Brandi L S; Oleggini M; Frediani M; Lachi S; Di Trani M; Ferrannini E
Inadvertent catheterization of the internal thoracic vein mimicking pulmonary embolism: a case report.
JPEN. Journal of parenteral and enteral nutrition 1988;12(2):221-2.
1988: Ferrannini E; DeFronzo R A; Gusberg R; Tepler J; Jacob R; Aaron M; Smith D; Barrett E J
Splanchnic amino acid and glucose metabolism during amino acid infusion in dogs.
Diabetes 1988;37(2):237-45.
1988: Brandi L S; Oleggini M; Lachi S; Frediani M; Bevilacqua S; Mosca F; Ferrannini E
Energy metabolism of surgical patients in the early postoperative period: a reappraisal.
Critical care medicine 1988;16(1):18-22.
1988: Ferrannini E; Simonson D C; Katz L D; Reichard G; Bevilacqua S; Barrett E J; Olsson M; DeFronzo R A
The disposal of an oral glucose load in patients with non-insulin-dependent diabetes.
Metabolism: clinical and experimental 1988;37(1):79-85.
1988: Felber J P; Golay A; Jéquier E; Curchod B; Temler E; DeFronzo R A; Ferrannini E
The metabolic consequences of long-term human obesity.
International journal of obesity 1988;12(5):377-89.
1987: Smith D; Rossetti L; Ferrannini E; Johnson C M; Cobelli C; Toffolo G; Katz L D; DeFronzo R A
In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies.
Metabolism: clinical and experimental 1987;36(12):1167-74.
1987: Felber J P; Ferrannini E; Golay A; Meyer H U; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo R A
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
Diabetes 1987;36(11):1341-50.
1987: Bevilacqua S; Bonadonna R; Buzzigoli G; Boni C; Ciociaro D; Maccari F; Giorico M A; Ferrannini E
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects.
Metabolism: clinical and experimental 1987;36(5):502-6.
1986: Ferrannini E; Barrett E J; Bevilacqua S; Jacob R; Walesky M; Sherwin R S; DeFronzo R A
Effect of free fatty acids on blood amino acid levels in human.
The American journal of physiology 1986;250(6 Pt 1):E686-94.
1985: Bevilacqua S; Barrett E J; Smith D; Simonson D C; Olsson M; Bratusch-Marrain P; Ferrannini E; DeFronzo R A
Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog.
Metabolism: clinical and experimental 1985;34(9):817-25.
1985: Barrett E J; Ferrannini E; Gusberg R; Bevilacqua S; DeFronzo R A
Hepatic and extrahepatic splanchnic glucose metabolism in the postabsorptive and glucose fed dog.
Metabolism: clinical and experimental 1985;34(5):410-20.
1984: Simonson D C; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo R A
Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
Diabetes 1984;33(9):838-45.
1983: Ferrannini E; Barrett E J; Bevilacqua S; DeFronzo R A
Effect of fatty acids on glucose production and utilization in man.
The Journal of clinical investigation 1983;72(5):1737-47.
1982: Barrett E J; DeFronzo R A; Bevilacqua S; Ferrannini E
Insulin resistance in diabetic ketoacidosis.
Diabetes 1982;31(10):923-8.
1982: Ferrannini E; Barrett E; Bevilacqua S; Dupre J; Defronzo R A
Sodium elevates the plasma glucose response to glucose ingestion in man.
The Journal of clinical endocrinology and metabolism 1982;54(2):455-8.
1981: Bevilacqua S; Barrett E; Ferrannini E; Gusberg R; Stewart A; Richardson L; Smith D; DeFronzo R
Lack of effect of parathyroid hormone on hepatic glucose metabolism in the dog.
Metabolism: clinical and experimental 1981;30(5):469-75.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ele Ferrannini

Research Profile (preview)

Chemicals & Drugs

Disorders

Devices

Procedures

Activities & Behaviors

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ele Ferrannini (preview)

All Publications